Toric Contact Lenses for Astigmatism
What You Need to Know Before You Apply
What is the purpose of this trial?
The aim of this study is to evaluate the agreement between subjective and objective toric lens prescriptions.
Are You a Good Fit for This Trial?
This trial is for adults 18 or older with astigmatism and certain vision prescriptions (+4.00 to -7.00DS, 0.75 to 2.25DC in one eye), who can see well with correction and currently wear or have recently worn soft contact lenses.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants are randomized to wear either lens A (stenfilcon A) or lens B (comfilcon A) to evaluate the agreement between subjective and objective toric lens prescriptions
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Trial Overview
The study compares two types of toric soft contact lenses (comfilcon A vs stenfilcon A) to see how well different ways of prescribing them match up, using both patient feedback and objective measurements.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
All participants will be randomized to wear lens B
All participants will be randomized to wear lens A
Find a Clinic Near You
Who Is Running the Clinical Trial?
CooperVision International Limited (CVIL)
Lead Sponsor
Dr. Patrizia Cavazzoni
CooperVision International Limited (CVIL)
Chief Medical Officer
MD from Harvard Medical School
Steven Robins
CooperVision International Limited (CVIL)
President, Americas
Bachelor of Arts from Bates College, participated in Pfizer Global Leadership Program with Harvard University
Indiana University
Collaborator
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.